The Clonab brand, founded in 1982 (Germany), from 21 sister brands and 2214 competing brands. Clonab is owned by Biotest, listed on the stock exchange of Francfort The International Securities Identification Number (ISIN) of Biotest is DE0005227201. Clonab is part of the Biotechnology activity sector.
Investment simulator :
Portfolio valuation
Biotest
(Clonab)
over 5 years*
EUR 73.60